CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01475058 |
|
Recruitment Status
:
Completed
First Posted
: November 21, 2011
Last Update Posted
: February 15, 2017
|
Sponsor:
Fred Hutchinson Cancer Research Center
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Cameron Turtle, Fred Hutchinson Cancer Research Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | April 2014 |
| Actual Study Completion Date : | July 2014 |
| Certification/Extension First Submitted : | January 31, 2017 |